Drug makers seeking new growth engines

Leading pharmaceutical companies here are scrambling to find new growth engines against a deteriorating business environment in the aftermath of the government’s forced price cut for drugs and other medical products covered by National Health Insurance.

Some have decided to increase research and development (R&D) activities to produce more lucrative, innovative medicines, while others seek t...